KFDA to bar wholesalers from selling subdivided drugs

Published: 2003-07-23 07:00:00

Updated: 2003-07-23 07:00:00

The Korea Food and Drug Administration unveiled a recent plan designed to prohibit drug wholesalers' selling of subdivided drugs and ease the regulations of drug advertisements as part of efforts to cope with some problems associated with the ongoing system of separating drug dispensing from medi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK